Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA05000619 2-Nonanol nonan-2-ol FOH 9:0 C9H20O 144.151415
LMFA05000612 2-Butyl-1-octanol 2-butyloctan-1-ol FOH 12:0 C12H26O 186.198365
LMFA07010824 Cyclohexyl butanoate cyclohexyl butanoate WE 10:1 C10H18O2 170.130680
LMFA07010824 Cyclohexyl butanoate cyclohexyl butanoate WE 10:1 C10H18O2 170.130680
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA07010842 Dodecyl 2-methylpropanoate dodecyl 2-methylpropanoate WE 16:0 C16H32O2 256.240231
LMFA07010842 Dodecyl 2-methylpropanoate dodecyl 2-methylpropanoate WE 16:0 C16H32O2 256.240231
LMFA07010438 hexyl hexanoate hexyl hexanoate WE 12:0 C12H24O2 200.177630
LMFA06000001 Enanthaldehyde heptanal FAL 7:0 C7H14O 114.104465
LMFA07070065 Glutaconylcarnitine (3S)-3-{[(2E)-4-carboxybut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 5:2;O2 C12H19NO6 273.121239
LMFA07070065 Glutaconylcarnitine (3S)-3-{[(2E)-4-carboxybut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 5:2;O2 C12H19NO6 273.121239
LMFA07070094 O-methylmalonylcarnitine 3-[(2-carboxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:1;O2 C11H19NO6 261.121239
LMFA07070094 O-methylmalonylcarnitine 3-[(2-carboxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:1;O2 C11H19NO6 261.121239
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07050219 3-hydroxyisoheptadecanoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-15-methylhexadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 17:0;O C38H68N7O18P3S 1035.355440
LMFA07010919 Isopentyl isopentanoate 3-methylbutyl 3-methylbutanoate WE 10:0 C10H20O2 172.146330
LMFA07010919 Isopentyl isopentanoate 3-methylbutyl 3-methylbutanoate WE 10:0 C10H20O2 172.146330
LMFA07010977 Nonyl isovalerate nonyl 3-methylbutanoate WE 14:0 C14H28O2 228.208930
LMFA07010977 Nonyl isovalerate nonyl 3-methylbutanoate WE 14:0 C14H28O2 228.208930
LMFA07070109 trans-Hexadec-2-enoyl carnitine 3-[(2E)-hexadec-2-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:1 C23H43NO4 397.319209
LMFA07070109 trans-Hexadec-2-enoyl carnitine 3-[(2E)-hexadec-2-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:1 C23H43NO4 397.319209
LMFA07010797 Butyl undecylenate butyl undec-10-enoate SFE 15:1 C15H28O2 240.208930
LMFA07010797 Butyl undecylenate butyl undec-10-enoate SFE 15:1 C15H28O2 240.208930
LMFA07010915 Isobutyl 2-furanpropionate 2-methylpropyl 3-(furan-2-yl)propanoate WE 11:3;O C11H16O3 196.109945
LMFA07010915 Isobutyl 2-furanpropionate 2-methylpropyl 3-(furan-2-yl)propanoate WE 11:3;O C11H16O3 196.109945
LMFA07010915 Isobutyl 2-furanpropionate 2-methylpropyl 3-(furan-2-yl)propanoate WE 11:3;O C11H16O3 196.109945
LMFA04020251 (4R,8S,11R)-d5-7-NeuroF[7R,10S] (R,E)-4-hydroxy-6-((2R,3S,5S)-3-hydroxy-5-((R,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA07010862 Ethyl 3-cyclohexylpropionate ethyl 3-cyclohexylpropanoate SFE 11:1 C11H20O2 184.146330
LMFA07010862 Ethyl 3-cyclohexylpropionate ethyl 3-cyclohexylpropanoate SFE 11:1 C11H20O2 184.146330
LMFA07010855 Ethyl 2-ethylhexanoate ethyl 2-ethylhexanoate SFE 10:0 C10H20O2 172.146330
LMFA07010855 Ethyl 2-ethylhexanoate ethyl 2-ethylhexanoate SFE 10:0 C10H20O2 172.146330
LMFA04020409 (8R,11S,14R)-d12-7-NeuroF[7S,10S] (Z)-6-((2S,3R,5S)-5-((1S,2E,4R,6Z,9Z)-1,4-dihydroxydodeca-2,6,9-trien-1-yl)-3-hydroxytetrahydrofuran-2-yl)hex-4-enoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA07050382 trans-2-Enoyl-OPC8-CoA CoA 18:4;O C39H62N7O18P3S 1041.308490
LMFA04020351 (11R,14S,17S)-d15-10-NeuroF[10R,13S] (4Z,7Z)-9-((2R,3R,5S)-5-((1S,2E,4S,6Z)-1,4-dihydroxynona-2,6-dien-1-yl)-3-hydroxytetrahydrofuran-2-yl)nona-4,7-dienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020292 (14S,17R,20R)-d18-13-NeuroF[13R,16R] (4Z,7Z,10Z)-12-((2R,3S,5R)-5-((1R,4R,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)dodeca-4,7,10-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA01060012 n-valeryl acetic acid 3-oxo-heptanoic acid FA 7:1;O C7H12O3 144.078645
LMFA04020008 delta18-13-NeuroF (4Z,7Z,10Z)-12-(5-((E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)dodeca-4,7,10-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020455 (7S,10R,13S)-d8-11-NeuroF[11S,14R] (4Z,7S,8E,10R)-7,10-dihydroxy-10-((2S,4S,5R)-4-hydroxy-5-((2Z,5Z)-octa-2,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,8-dienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA04020006 delta15-10-NeuroF (4Z,7Z)-9-(5-((2E,6Z)-1,4-dihydroxynona-2,6-dien-1-yl)-3-hydroxytetrahydrofuran-2-yl)nona-4,7-dienoic acid FA 22:5;O4 C22H34O6 394.235541